ClinicalTrials.Veeva

Menu

Long-term Outcomes of Duodenal Adenocarcinoma From a Large Cohort

N

Nanfang Hospital, Southern Medical University

Status

Not yet enrolling

Conditions

Gastrointestinal Disease

Treatments

Procedure: Radical operation and perioperative therapy

Study type

Observational

Funder types

Other

Identifiers

NCT06443086
NFEC-2024-171

Details and patient eligibility

About

The investigators will conducted a hospital-based cohort study in our 15-year experience with DA aimed at investigating the long-term outcomes of the patients with DA, along with analyzing the impact of the tumor characteristics, operations and adjuvant therapy on survival outcomes.

Full description

Numerous meta-analyses and systematic reviews have delved into the treatment of DA, yet the majority of the studies retrospective, single-center, and small sample size series, particularly in China. To bridge this knowledge gap, the investigators will conduct a hospital-based cohort study designed to investigate the long-term survival outcomes of the participants with the non-ampulla duodenal adenocarcinoma, and the effects of tumor characteristics, surgery, and adjuvant therapy on survival outcomes.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

(1) histologically confirmed non-ampulla DA;

Exclusion criteria

  1. had other gastrointestinal cancer;
  2. had incomplete medical records, or lost follow-up shortly after diagnosis;
  3. refused clinical data collection.

Trial design

400 participants in 1 patient group

Duodenal carcinoma patients
Description:
The patients included in this study were drawn from a hospital-based cohort and included cases diagnosed and treated at the facility. Inclusion criteria were histologically confirmed non-ampulla DA, including all stages of disease at diagnosis. Patients were excluded if they had ampulla cancer or other forms of gastrointestinal cancer, had incomplete medical records, or lost follow-up shortly after diagnosis. This rigorous selection process ensured the homogeneity of the study population and the relevance of the findings to non-ampulla DA.
Treatment:
Procedure: Radical operation and perioperative therapy

Trial documents
2

Trial contacts and locations

0

Loading...

Central trial contact

Hao Liu, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems